Search

everythinglearnresearchcommunity

for

Search:↓

Ginsenoside Rf from Panax ginseng promotes hair growth and could be a natural alternative for treating hair loss.

Lupeol shows promise for hair growth but needs better absorption and safety testing.

Some drugs linked to growth hormones may increase the chance of hair loss in women.

GLP-1RA therapy may increase the risk of hair loss.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

Gestrinone pellets may help reduce pelvic pain in endometriosis safely.

Lichen planus pigmentosus is hard to treat and may be more common in North Africa than previously thought.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Researchers found a new genetic mutation linked to a hair condition in a Japanese boy.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Epiprofin suppresses parathyroid hormone gene activity, helping regulate calcium levels and could be a treatment target for hyperparathyroidism.

Progesterone protects brain cells by converting to allopregnanolone and involving GABAA receptors.

The study found a specific peptide that helps detect TGase 3 activity in skin and hair follicles.

GLPLS is a rare skin condition with specific hair loss and skin symptoms.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Nε-(carboxymethyl) lysine delays hair growth by blocking a key protein.

Paeonia lactiflora and Poria cocos extracts can potentially increase hair growth and reduce hair loss symptoms by lowering testosterone and inflammation levels.

DNAJB9 cfRNA could help diagnose and treat female hair loss.

Transglutaminases work through a ping-pong mechanism, and human plasma and platelet transglutaminases have similar catalytic subunits.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Hydroxychloroquine is ineffective for treating frontal fibrosing alopecia with lupus erythematosus.

PRP treatment improved skin pigmentation and appearance in facial lichen planus pigmentosus.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.

Elevated luteinizing hormone contributes to female-pattern hair loss, and blocking certain channels may help prevent it.

GLP-1 agonists may help treat certain skin conditions.

Blood count parameters are not reliable for predicting recurrent implantation failure.

A patient with "strawberry gingivitis" improved after correct treatment for Granulomatosis with polyangiitis, highlighting the need for early diagnosis.

Rhus semialata gall extract and Penta-O-Galloyl-β-D-Glucose may effectively reduce hair loss.